Here, we report a case of Burkitt's lymphoma in which an upper GI adverse event occurred during immune consolidation therapy after chemotherapy combined with autologous stem cell transplantation, expected to provide a reference for the broader application of PD-1 inhibitors in non-Hodgkin's lymphoma. This evidence concerns the gene PDCD1 and non-Hodgkin lymphoma.